TNXP


Top 20 Biotech Stocks for 2015.

Chicago IL / Research Report Wire / February 27th, 2015 / Institutional Analyst Inc.(IA) announced today it released the its Top 20 Biotech …

Roth Capital Reiterates Buy On Tonix Pharmaceuticals Following FDA Meeting Update

In a research report sent to investors today, Roth Capital analyst Scott Henry reiterated a Buy rating on Tonix Pharmaceuticals (NASDAQ:TNXP) with a …

Roth Capital Reiterates Buy On Tonix Pharmaceuticals As Risk-Reward Is Favorable

Roth Capital analyst Scott Henry reiterated a Buy rating on Tonix Pharmaceuticals (NASDAQ:TNXP) with a $10 price target, following the company’s third-quarter results. reporting a 3Q14 EPS …

Tonix Pharmaceuticals: Analyst Day Confirms Bullish Thesis, Says Roth Capital

Roth Capital analyst Scott Henry reiterated a Buy rating on Tonix Pharmaceuticals (NASDAQ:TNXP) with a price target of $10.00, which represents a potential upside …

Roth Capital Maintains Buy On Tonix Pharma, Cuts PT To $10

In a research report released today Roth Capital analyst Scott Henry maintained a Buy rating on Tonix Pharmaceuticals (NASDAQ:TNXP) but lowered his price …

Tonix Pharmaceuticals Quarterly Update; Roth Capital Reiterates Buy

In a research note issued August 11, Roth Capital analyst Scott Henry maintained coverage with a Buy rating on Tonix Pharmaceuticals (TNXP) and a $17 price target, following the …

Roth Capital Maintains Buy Rating On Tonix Following A Physician Conference Call

In a research note issued today, Roth Capital analyst Scott Henry maintained coverage with a “Buy” rating on Tonix Pharmaceuticals Holding Corp (TNXP) and a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts